BSECompany Update29 Oct 2026 · 29 Oct 2026, 04:36 pm

The relevant disclosure is attached

Fortis Healthcare Ltd · 532843

✦ AI SummaryResults

Fortis Healthcare Ltd has announced a conference call to discuss its unaudited financial results for Q2FY27 and H1FY27.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

ed16fa66-6379-4eeb-9664-230698f448bb.pdf

pdf

Download →
View document text
Fortis Healthcare Limited Tower-A, Unitech Business Park, Block-F, South City 1, Sector – 41, Gurgaon, Haryana – 122 001 (India) Tel : 0124 492 1033 Fax : 0124 492 1041 Emergency : 105010 Email : secretarial@fortishealthcare.com Website : www.fortishealthcare.com October 29, 2026 FHL/SEC/2026-27 The National Stock Exchange of India Ltd. BSE Limited Scrip Symbol: FORTIS Scrip Code: 532843 Sub: Intimation for schedule of Investors / Analysts’ meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Madam/Sir, In compliance of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below schedule of upcoming conference call invite to discuss the Company’s Unaudited financial results for the quarter ended September 30, 2026: Sr. Date & Time Investors / Analysts / Mode of Type of Location No Events Meeting Meeting 1 Friday, November Q2FY27 Post Results Virtual Group call Virtual 06, 2026 at 11.00 am Conference Call Invite Conference (1100 hrs IST) Please note that the above schedule and timings are subject to changes due to exigencies on the part of the Investors/Company. No Unpublished Price Sensitive Information (UPSI) shall be shared / discussed at the investor meet. This is for your kind information and records. Thanking you, Yours Sincerely, For Fortis Healthcare Limited Satyendra Chauhan Company Secretary & Compliance Officer ICSI Membership: A14783 FORTIS HEALTHCARE LIMITED Regd. Office : Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel : 0172-4692222, Fax : 0172-5096221, CIN : L85110PB1996PLC045933 Q2FY27 Post Results Conference Call Invite Fortis Healthcare Limited The Management of Fortis Healthcare Limited invites you for a conference call on Friday, November 06, 2026 at 11.00 am (1100 hrs IST) to discuss the Company’s Q2FY27 and H1FY27 unaudited financial results. Details of the conference call are as under: Date: November 06, 2026 India participants India Dial-In Number Time Primary Number +91 22 6280 1307 / 7115 8208 11.00 am Accessible from all carriers. International participants International Dial-In Number Time (Toll Free) UK 0 808 101 1573 05:30 am US (NY Time) 1 866 746 2133 12:30 am Singapore 800 101 2045 01:30 pm Hong Kong 800 964 448 01:30 pm Replay Number - India: (Playback ID: 57650) Number Date +91 22 7194 5757 November 06, 2026 – November 13, 2026 Connect to your call without having to wait for an operator. It's easy, It's convenient, It's effective. Express Join with DiamondPass™ No Wait Time https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=5384494&linkSecurityString= 2f0c96d87e The above button has been hyperlinked for this specific conference only and should not be re-used for other calls. For further information please contact: Amit Mahendru | Fortis Healthcare Limited | Email: amit.mahendru@fortishealthcare.com